Is It Time to Abandon Warfarin and Embrace Oral Direct Thrombin Inhibitors to Prevent Stroke in Patients With Atrial Fibrillation?
Rudy J. Rahme(Northwestern University), Bernard R. Bendok(Northwestern University), H. Hunt Batjer(The University of Texas Southwestern Medical Center), Richard A. Bernstein(Northwestern University)
Cited by 1
Related Papers
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study
|The Lancet Neurology|2012|775